(0.25%) 5 308.50 points
(0.23%) 38 881 points
(0.38%) 18 661 points
(0.03%) $77.01
(3.90%) $2.69
(-0.02%) $2 345.40
(-0.25%) $30.37
(0.15%) $1 043.60
(0.05%) $0.922
(0.01%) $10.49
(0.08%) $0.786
(-0.86%) $89.65
0.15% $ 0.0649
Live Chart Being Loaded With Signals
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics...
Stats | |
---|---|
Volumen de hoy | 1 200.00 |
Volumen promedio | 0.00 |
Capitalización de mercado | 42.25M |
EPS | $-0.000290 ( 2023-06-29 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-28 | Desai Arjun Jj | Buy | 33 040 | Stock Options (Right to buy) |
2023-11-28 | Jacobovitz Shalom | Buy | 42 736 | Stock Options (Right to buy) |
2023-11-28 | Matlin David J | Buy | 56 024 | Stock Options (Right to buy) |
2023-11-28 | Kiernan Matthew | Buy | 28 730 | Stock Options (Right to buy) |
2023-11-28 | Mosca Alison | Buy | 43 814 | Stock Options (Right to buy) |
INSIDER POWER |
---|
99.47 |
Last 99 transactions |
Buy: 47 544 964 | Sell: 666 194 |
Clene Inc. Correlación
10 Correlaciones Más Negativas | |
---|---|
BOTT | -0.804 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Clene Inc. Finanzas
Annual | 2023 |
Ingresos: | $654 000 |
Beneficio Bruto: | $-1.17M (-179.20 %) |
EPS: | $-0.470 |
FY | 2023 |
Ingresos: | $654 000 |
Beneficio Bruto: | $-1.17M (-179.20 %) |
EPS: | $-0.470 |
FY | 2022 |
Ingresos: | $473 000 |
Beneficio Bruto: | $447 000 (94.50 %) |
EPS: | $-0.230 |
FY | 2021 |
Ingresos: | $723 000 |
Beneficio Bruto: | $434 000 (60.03 %) |
EPS: | $0 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Clene Inc.
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain\'s energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson\'s Diseases. The company\'s products also include CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease, such as COVID-19 and to provide immune support for symptom resolution. It also markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico